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I N T R O D U C T I O N
Radiofrequency ablation (RFA) of the pulmonary veins is an effective and widely 
used therapy for symptomatic patients with atrial fibrillation.1 The reported compli-
cation rate after RFA is 3.9% to 22%2 and the mortality rate is 2% to 4%3 among 
all patients. We report a case in which a cardiac myxoma arose in a patient’s apical 
interventricular septum of his left ventricle after RFA.
C A S E  P R E S E N T A T I O N
A 65-year-old Caucasian man with a history of hypertension and paroxysmal atrial 
fibrillation (PAF) was admitted to our hospital. On admission patient’s heart rhythm 
was irregular (135 bpm) and his blood pressure was 130/68 mmHg. A 12-lead electro-
cardiogram revealed atrial fibrillation. 
A two-dimensional transthoracic echocardiography (TTE) was performed, which 
showed a large, pedunculated, mobile mass sized 15×18 mm located at the apical 
interventricular septum of the left ventricle, with a normally contracting adjacent 
myocardium (Figure 1a, b). Left ventricular systolic function and the morphology and 
function of cardiac valves were normal. Further evaluation with cardiac computed 
tomography (CT) confirmed the presence of a nodular pedunculated mass (14×10 
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CT = computed tomography 
PAF = paroxysmal atrial fibrillation 
RFA = radiofrequency ablation 
TTE = transthoracic echocardiography
FIgURE 1. Transthoracic echocardiography apical two-chamber view in (a) systole and 
(b) diastole. A large pedunculated mass at the apical interventricular septum is seen (ar-
rows).
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FIgURE 2. CT (a) 2-chamber and (b) 4-chamber axial view im-
ages revealing a nodular mass at the apical interventricular sep-
tum of the left ventricle. F: Foot, R: Right, A: Apex.
FIgURE 3. Transthoracic echocardiography apical two-chamber 
view in (a) systole and (b) diastole. 12 months earlier no mass is 
seen in this view.
(CARTO®, Biosense-Webster; Israel). Radiofrequency abla-
tion was performed until complete isolation of the pulmonary 
veins from the left atrium was achieved. The procedure was 
completed without clinically relevant sequelae. TTE and chest 
CT performed prior to and following the ablation procedure 
did not demonstrate any left ventricular mass (Figures 3a, b 
and 4a, b). 
Since the onset of symptoms was 3 hours prior to admis-
sion, patient was hemodynamically stable and on warfarin 
with prothrombin time in therapeutic levels, we proceeded 
and successfully converted atrial fibrillation to sinus rhythm 
with intravenous amiodarone. The patient was subsequently 
scheduled for urgent cardiac surgery. Under cardiopulmonary 
bypass, a left apical 2.5 cm longitudinal ventriculotomy was 
performed, which exposed the mass in full view (Figure 5). 
The defect was closed in a linear fashion and reinforced with 
felt strips. A histopathology examination demonstrated the 
typical features of a myxoma (Figure 6). 
Following the resection of the myxoma and over 20 months 
mm) with radiographic evidence of myxoma (Figure 2a, b). 
No signs of peripheral embolic events were detected.
Interestingly, one year earlier the patient had undergone 
a radiofrequency ablation (RFA) procedure for pulmonary 
vein isolation for PAF. RFA was performed with use of 
the transseptal technique; mapping of pulmonary veins was 
performed with a circumferential mapping catheter guided 
by a magnetic-based 3-dimensional (3D) mapping system 
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FIgURE 4. CT (a) 2-chamber and (b) 4-chamber axial view im-
ages performed 12 months prior to clinical attendance. No mass 
is seen. F: Foot, R: Right, A: Apex
myxomas. Although the number of asymptomatic cardiac tu-
mors being detected has increased due to the widespread use 
of echocardiography, left ventricular myxomas are still rare 
and the diagnosis is often preceded by syncope caused by left 
ventricular outflow tract obstruction or systemic embolization. 
The exact etiology of myxomas is unknown and most cases 
are sporadic. Familial atrial myxomas have an autosomal-
dominant transmission, but these account for <10% of the 
total number of myxomas. Although familial myxomas may be 
transmitted without any associated disorders, they may present 
as a component of a Carney complex, an autosomal-dominant 
condition comprising myxomas at various sites, endocrine tu-
mors, and spotty pigmentation of the skin. It is well accepted 
FIgURE 5. Intraoperative photo showing the mass through an 
apical left ventriculotomy.
of follow-up, repeat echocardiographic and CT examinations 
have not shown any evidence of tumor recurrence. Interest-
ingly the patient has also been free of any PAF episodes.
D I S C U S S I O N 
Left ventricular myxomas are more common in women and 
may arise from any region of the left ventricle, in contrast to 
atrial myxomas, which usually originate from the interatrial 
septum. Whereas atrial myxomas are usually associated with 
symptoms and signs of systemic illness, such as weight loss, 
fatigue, fever, anemia, and leukocytosis,4 these symptoms 
and signs are usually not observed in patients with ventricular 
FIgURE 6. Histopathology of the excised mass shows myxoid 
stroma containing single and small groups of lepidic cells and a 
few small vessels.
4HOSPITAL CHRONICLES 2014, VOLUME 9, SUPPLEMENT 1: «ATHENS CARDIOLOGY UPDATE 2014»
tion of accessory pathways: a 14 year experience at the Tel Aviv 
Medical Center in 508 patients. Isr Med Assoc J 2007; 9:265-270. 
2. Abhishek F, Heist EK, Barrett C, et al. Effectiveness of a strat-
egy to reduce major vascu- lar complications from catheter 
ablation of atrial fibrillation. J Interv Card Electrophysiol 2011; 
30:211-215.
3. Hahn K, Gal R, Sarnoski J, Kubota J, Schmidt DH, Bajwa TK. 
Transesophageal echocardiographically guided atrial transsep-
tal catheterization in patients with normal-sized atria: incidence 
of complications. Clin Cardiol 1995; 18:217-220.
4. Artel B, Colvin SB, Kronzon I. Rapid growth rate of an apical 
left ventricular myxoma. Am Heart J 1996, 131:820–822.
5. Reardon MJ, Smythe WR. Cardiac neoplasms. In: Cohn LH, 
Edmunds LH Jr, editors. Cardiac surgery in the adult. 2nd ed. 
New York: McGraw-Hill; 2003. p. 1373-400.
6. Zhang FX, Yang B, Chen HW, Ju WZ, Cao KJ, Chen ML. My-
ocardial injury resulting from radiofrequency catheter ablation: 
comparison of circumferential pulmonary vein iso- lation and 
complex fractionated atrial electrograms ablation. Chin Med J 
2011; 124:2674-2677.
7. Alvarez JR, Martinez de Alegria A, Quiroga JS, Nazar BA, Ta-
boada CR, Martinez JM. Rapid growth of left atrial myxoma 
after radiofrequency ablation. Tex Heart Inst J 2013; 40:459-461. 
that myxomas can develop after cardiac trauma including the 
repair of atrial septal defects and transseptal puncture for 
dilation of the mitral valve.5
Radiofrequency ablation necessarily produces an area of 
myocardial necrosis. Several biochemical markers have been 
used for the diagnosis of RFA-induced myocardial damage.6 
The appearance of an atrial myxoma after RFA has, to our 
knowledge, been previously reported only once in the litera-
ture.7
In our patient the development of the myxoma was in a 
position that can not be associated with the RFA procedure 
per se and its discovery seems to be a coincidence. A very 
interesting observation in this case report is the amelioration 
of PAF episodes after the resection of the myxoma. A possible 
explanation of this finding may be based on the activation of 
neurohormones and cytokine overexpression form the tumor. 
Further observations are needed in order to establish this 
relationship.
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